Vanda Pharmaceuticals
VNDA
VNDA
135 hedge funds and large institutions have $934M invested in Vanda Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 54 increasing their positions, 43 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.55% less ownership
Funds ownership: 94.63% → 94.08% (-0.55%)
5% less call options, than puts
Call options by funds: $683K | Put options by funds: $722K
Holders
135
Holding in Top 10
3
Calls
$683K
Puts
$722K
Top Buyers
| 1 | +$29.3M | |
| 2 | +$18.2M | |
| 3 | +$13.2M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$5.5M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$5.26M |
Top Sellers
| 1 | -$17.2M | |
| 2 | -$11.5M | |
| 3 | -$7.33M | |
| 4 |
AC
Armistice Capital
New York
|
-$7.16M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$5.52M |